Appunti VERIFICATO

Lezione 2 - clinical virology and antiviral resistance

Università degli studi di Siena medical biotechnologies - biotecnologie mediche 2021
68 visualizzazioni
Nessun voto ancora
Condividi: WhatsApp Telegram
Anteprima pagina 1 — Lezione 2 - clinical virology and antiviral resistance Anteprima pagina 2 — Lezione 2 - clinical virology and antiviral resistance Anteprima pagina 3 — Lezione 2 - clinical virology and antiviral resistance

Stai vedendo l'anteprima delle prime pagine. Registrati per sbloccare le pagine restanti.

Di cosa parla

  • Virus cross-species transmission: Examples include rabies, Ebola, Dengue, and HIV, showing how viruses can evolve to infect new hosts.
  • Bats as virus reservoirs: Many viruses like Ebola, SARS, MERS originate from bats, highlighting their role in emerging viral diseases.
  • Human-to-human transmission: Cases of H5N1 influenza and SARS illustrate the potential for viruses to spread among humans.
  • Virus variability and immune escape: Mutations can lead to epitope changes, allowing viruses to evade immune recognition.
  • Phylogenetic analysis of hepatitis C virus: Demonstrates how individual immune systems influence viral mutation patterns.
  • Emergent drug resistance: Antiviral drugs can select for resistant viral variants due to variability.
  • Vaccine escape: Large vaccination campaigns can exert pressure on viruses, leading to the emergence of vaccine-resistant strains.
  • Innate and adaptive immunity: Innate immunity is a first-line defense with limited specificity but triggers adaptive immunity. Adaptive immunity provides specific responses and immunological memory.

Registrati e sblocca subito 3 appunti gratis, questo incluso.

Altri appunti di CLINICAL VIROLOGY AND ANTIVIRAL RESISTANCE

Condividi questi appunti

WhatsApp Telegram